论文部分内容阅读
本文报导了30例淋巴系统造血器官肿瘤施行的VAD 疗法。30例中除浆细胞白血病1例,非霍奇金病1例为初治病例外,余28例均为对多种化疗药耐药的难治病例。30例中男21例,女9例。年龄21～86岁。疾病分类:多发性骨髓瘤(MM)8例,浆细胞白血病(PCL)2例,急性淋巴细胞白血病(ALL)5例,慢粒急变1例,慢淋急变1例,成人T 细胞白血病1例,非霍奇金病(NHL)9例,霍奇金病(HD)3例。VAD 疗法的方法:长春新碱(VCR)0.4mg/天,阿霉素(ADM)9mg/m~2/天,每日一次静滴,连用4日。地塞米松(DXM)40mg/天,每日一次口服,连用4
This article reports on VAD therapy in 30 hematopoietic malignancies of the lymphatic system. Thirty cases except plasma cell leukemia in 1 case, non-Hodgkin’s disease in 1 case of newly diagnosed cases, the remaining 28 cases were resistant to a variety of chemotherapy drugs refractory cases. There were 21 males and 9 females in 30 cases. Age 21 ~ 86 years old. Classification of diseases: 8 cases of multiple myeloma (MM), 2 cases of plasma cell leukemia (PCL), 5 cases of acute lymphoblastic leukemia (ALL), 1 case of acute myeloid leprosy, 1 case of acute leprosy, 1 case of adult T cell leukemia , 9 cases of non-Hodgkin’s disease (NHL) and 3 cases of Hodgkin’s disease (HD). Methods of VAD therapy: vincristine (VCR) 0.4mg / day, adriamycin (ADM) 9mg / m ~ 2 / day, intravenous infusion once daily for 4 days. Dexamethasone (DXM) 40mg / day, once daily oral, used in combination 4